Please review our updated Privacy & Cookies Notice.

We use cookies and similar technologies to collect information and to personalize the site. By continuing to use this site, you consent to the placement of these cookies and similar technologies and to our privacy practices.

Read our updated Privacy & Cookies Notice to learn more.

About

Learn about our origins, operations, leadership, job opportunities, and more.

Our work

Learn about the foundation teams and programs that are making an impact around the globe.

Ideas

Read the latest stories, interviews, and insights from across the foundation.

Learn about our origins, operations, leadership, job opportunities, and more.

Learn about the foundation teams and programs that are making an impact around the globe.

Read the latest stories, interviews, and insights from across the foundation.

Merck Sharp & Dohme Corp.

Grantee Website Kenilworth, New Jersey, United States

Purpose

to develop an oral once-monthly pill for HIV prevention

Grantee

Division

Global Health

Year Awarded

2021

Region Served

GLOBAL

Committed Amount

$45,549,976

Grant Topic

HIV

Duration (Months)

46

Grantee Location

Kenilworth, New Jersey, United States

More about our work

Our story

Learn about the origins of the foundation and the values that drive our work.

Learn more

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

Learn more

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.

Learn more